213 related articles for article (PubMed ID: 10449755)
1. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.
Ge K; DuHadaway J; Du W; Herlyn M; Rodeck U; Prendergast GC
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9689-94. PubMed ID: 10449755
[TBL] [Abstract][Full Text] [Related]
2. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
3. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
4. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity.
Ge K; Duhadaway J; Sakamuro D; Wechsler-Reya R; Reynolds C; Prendergast GC
Int J Cancer; 2000 Feb; 85(3):376-83. PubMed ID: 10652430
[TBL] [Abstract][Full Text] [Related]
5. Bin1 mediates apoptosis by c-Myc in transformed primary cells.
DuHadaway JB; Sakamuro D; Ewert DL; Prendergast GC
Cancer Res; 2001 Apr; 61(7):3151-6. PubMed ID: 11306501
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.
Wechsler-Reya R; Sakamuro D; Zhang J; Duhadaway J; Prendergast GC
J Biol Chem; 1997 Dec; 272(50):31453-8. PubMed ID: 9395479
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.
Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC
Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240
[TBL] [Abstract][Full Text] [Related]
8. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
10. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
[TBL] [Abstract][Full Text] [Related]
11. Bau, a splice form of Neurabin-I that interacts with the tumor suppressor Bin1, inhibits malignant cell transformation.
Duhadaway J; Rowe F; Elliott K; Mao NC; Prendergast GC
Cell Adhes Commun; 1999; 7(2):99-110. PubMed ID: 10427963
[TBL] [Abstract][Full Text] [Related]
12. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
[TBL] [Abstract][Full Text] [Related]
13. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
[TBL] [Abstract][Full Text] [Related]
14. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
Sakamuro D; Elliott KJ; Wechsler-Reya R; Prendergast GC
Nat Genet; 1996 Sep; 14(1):69-77. PubMed ID: 8782822
[TBL] [Abstract][Full Text] [Related]
15. Splicing Regulator p54
Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
[TBL] [Abstract][Full Text] [Related]
16. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the expression of Bin1, a putative suppressor, in human hepatoma cells.
Livezey KW; Negorev D; Simon D
Cancer Genet Cytogenet; 2000 Jan; 116(1):35-9. PubMed ID: 10616529
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.
Muller AJ; DuHadaway JB; Donover PS; Sutanto-Ward E; Prendergast GC
Cancer Biol Ther; 2004 Dec; 3(12):1236-42. PubMed ID: 15611650
[TBL] [Abstract][Full Text] [Related]
19. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells.
Wechsler-Reya R; Elliott K; Herlyn M; Prendergast GC
Cancer Res; 1997 Aug; 57(15):3258-63. PubMed ID: 9242458
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein.
Galderisi U; Di Bernardo G; Cipollaro M; Jori FP; Piegari E; Cascino A; Peluso G; Melone MA
J Cell Biochem; 1999 Sep; 74(3):313-22. PubMed ID: 10412034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
